Malte - anglais - Medicines Authority

crescent pharma international limited 260, triq san albert, gzira gzr 1150, malta - imipramine hydrochloride - coated tablet - imipramine hydrochloride 25 mg - psychoanaleptics

Malte - anglais - Medicines Authority

remedica limited limassol industrial estate, aharnon street, 3056 limassol, cyprus - imipramine hydrochloride - coated tablet - imipramine hydrochloride 25 mg - psychoanaleptics

Pays-Bas - néerlandais - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

centrafarm b.v. - imipraminehydrochloride samenstelling overeenkomend met ; imipramine - omhulde tablet - arabische gom (e 414) ; calciumcarbonaat (e 170) ; cellulose, microkristallijn (e 460) ; erythrosine (e 127) ; hypromellose (e 464) ; ijzeroxide geel (e 172) ; ijzeroxide rood (e 172) ; lactose 1-water ; macrogolglycerolricinoleaat ; magnesiumstearaat (e 470b) ; maÏszetmeel ; methylparahydroxybenzoaat (e 218) ; montaanglycolwas (e 912) ; natriumbenzoaat (e 211) ; povidon k 25 (e 1201) ; propyleenglycol (e 1520) ; saccharose ; siliciumdioxide (e 551) ; talk (e 553 b) ; titaandioxide (e 171), - imipramine

États-Unis - anglais - NLM (National Library of Medicine)

geigy pharmaceuticals - imipramine hydrochloride (unii: bke5q1j60u) (imipramine - unii:ogg85sx4e4) - injection, solution - 25 mg in 2 ml - depression : for the relief of symptoms of depression. endogenous depression is more likely to be alleviated than other depressive states. one to three weeks of treatment may be needed before optimal therapeutic effects are evident. the concomitant use of monoamine oxidase inhibiting compounds is contraindicated. hyperpyretic crises or severe convulsive seizures may occur in patients receiving such combinations. the potentiation of adverse effects can be serious, or even fatal. when it is desired to substitute tofranil in patients receiving a monoamine oxidase inhibitor, as long an interval should elapse as the clinical situation will allow, with a minimum of 14 days. initial dosage should be low and increases should be gradual and cautiously prescribed. the drug is contraindicated during the acute recovery period after a myocardial infarction. patients with a known hypersensitivity to this compound should not be given the drug. the possibility of cross-sensitivity to other dibenzazepine compounds should be k

Australie - anglais - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - imipramine hydrochloride -

Australie - anglais - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - imipramine hydrochloride -

Chypre - grec - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

remedica ltd (0000003171) aharnon str., lemesos, 3056 - imipramine hydrochloride - film coated tablets - 25mg - imipramine hydrochloride (0000113520) 25mg - imipramine

Chypre - grec - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

remedica ltd (0000003171) aharnon str., lemesos, 3056 - imipramine hydrochloride - film coated tablets - 100mg - imipramine hydrochloride (0000113520) 100mg - imipramine

Chypre - grec - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

remedica ltd (0000003171) aharnon str., lemesos, 3056 - imipramine hydrochloride - film coated tablets - 10mg - imipramine hydrochloride (0000113520) 10mg - imipramine

Chypre - grec - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

remedica ltd (0000003171) aharnon str., lemesos, 3056 - imipramine hydrochloride - tablet, coated - 25mg - imipramine hydrochloride (0000113520) 25mg - imipramine